Dr. Ted Ryser, MD (he/him) is a Dermatologist in Nampa, ID with over 9 years of experience. What is your opinion of Dr. Ted Ryser, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 9 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Ted Ryser, MD has received over $701 which includes payments from the following companies:
$418.16 from AbbVie, Inc.
$75.38 from Regeneron Healthcare Solutions, Inc.
$46.82 from Novartis Pharmaceuticals Corporation
$21.22 from Celgene Corporation
$20.76 from LEO Pharma Inc.
$18.91 from Merck Sharp & Dohme Corporation
$16.98 from Janssen Biotech, Inc.
$16.89 from UCB, Inc.
$15.92 from Galderma Laboratories, L.P.
$13.39 from LILLY USA, LLC
$12.50 from Pfizer Inc.
$12.47 from Helsinn Therapeutics (U.S.), Inc.
$11.94 from Sun Pharmaceutical Industries Inc.
Payments received by Dr. Ted Ryser, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!
Diabetes and Skin Problems. Why People with Diabetes Need To See DermatologistSkin problems are common among people with diabetes. According to scientific studies, 54 to 71% of people with type 1 or type 2 diabetes have at least one skin condition related to their disease. Such conditions can often lead to dermatological complications that require professional attention,...